meningitidis microcolonies through interaction with meningococcal pili, interfering with microcolonies stability and meningococcal infection dynamics (Lidberg et al., 2025a)
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
TB-500 Loading: 1,250 mcg twice weekly for 4 weeks (total ~2.5 mg/week)
Jones, Ph.D., professor in the division of pulmonary medicine at Emory University (3)
Cancer Res 56 (15): 35773582
That can lead to: Muscle weakness QT prolongation Cardiac arrhythmias In severe cases, cardiovascular instability Why does this happen